- Managing type 2 diabetes mellitus.
- Improving glycemic control.
- Reducing HbA1c levels.
- Minimizing the risk of cardiovascular events in diabetic patients.
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, used in the management of type 2 diabetes mellitus. As a selective and potent DPP-4 inhibitor, it enhances glycemic control by increasing endogenous incretin hormones, such as GLP-1 and GIP, which stimulate insulin release and reduce glucagon secretion. Linagliptin is characterized by its once-daily dosing regimen, a low potential for drug-drug interactions, and a favorable side effect profile. It is a valuable therapeutic option for individuals with type 2 diabetes who require adjunctive treatment to improve blood glucose control while minimizing the risk of hypoglycemia and other adverse effects.
Composition
Each film coated tablet contains:
-
Linagliptin: 5 mg
Suggested Usage
- Use only as directed by the physician.
Legal Disclaimer
Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.
